NCT02083965 - Pharmacokinetics of rFVIIIFc at Two Vial Strengths | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

May 31, 2015

Conditions

Severe Hemophilia A

Interventions

BIOLOGICAL

rFVIIIFc

Administered as specified in the treatment arm.

Trial Locations (8)

Research Site, Salt Lake City

Research Site, Los Angeles

Research Site, Seattle

Research Site, Herston

Research Site, Perth

Research Site, Basingstoke

Research Site, Cambridge

Research Site, London